SELECT-SLE: Biomarker-Guided CAR-T Target Selection for Refractory Lupus
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Phase 1/2 Window Of Opportunity Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cells Delivered Intraperitoneally For The Management Of Gastric Cancer Metastatic To The Peritoneum
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Dual-Target GD2/B7-H3 CAR-NK Cells for Pediatric Relapsed or Refractory Neuroblastoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Dual-Target GPC3/B7-H3 CAR-NK Cells for Advanced HCC
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Chidamide Combination With R-mini CHOP Followed by Chidamide+CD20 Maintenance in Elderly Newly Diagnosed MYC/BCL2+ DLBCL
- Status
- RECRUITING
- Phase
- PHASE2
Dual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Study of Universal CD19 CAR-γδ T Cell Infusion in the Treatment of Relapsed/Refractory Acute B Lymphoblastic Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Allogeneic CD19/BCMA-Targeted CAR-γδT Cell Therapy: Safety and Preliminary Pharmacodynamics in Relapsed/Refractory Autoimmune Diseases
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma
- Status
- RECRUITING
- Phase
- PHASE1
Treatment of Orelabrutinib+Hi-CVP Regimen for Previously Untreated MZL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy
- Status
- RECRUITING
- Phase
- PHASE3
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE2
Testing the Addition of an Anti-Cancer Drug, Glofitamab, to the Usual Chemotherapy Treatment (Alternating R-CHOP/R-DHAP) for Previously Untreated Mantle Cell Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Phase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Phase III Study of KN026 in Combination With HB1801 as Adjuvant Therapy for Resectable HER2-Positive Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2